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Abstract
Background: Mutations in OTOF and PJVK genes cause DFNB9 and DFNB59 types of hearing loss, respectively. The patients
carrying pathogenic mutations in either of these genes may show the typical phenotype of auditory neuropathy spectrum
disorder (ANSD). The aim of the present study was to identify OTOF and PJVK mutations in sporadic ANSD patients.
Methods and Findings: A total of 76 unrelated Chinese non-syndromic ANSD patients were sequenced on the gene OTOF
and PJVK exon by exon. Variants were valued in 105 controls with normal hearing to verify the carrying rate. We identified
one pathogenic mutation (c.1194T.A) and three novel, possibly pathogenic, variants (c.3570+2T.C, c.4023+1G .A, and
c.1102G.A) in the OTOF gene, and one novel, possibly pathogenic, variant (c.548G.A) in PJVK. Moreover, we found three
novel missense mutations within the exons of OTOF.
Conclusions: As we identified 4 and 1 possible pathogenic variants of the OTOF gene and the PJVK gene, respectively, we
believe that screening in these genes are important in sporadic ANSD patients. The pathogenicity of these novel mutations
needs further study because of their single heterozygous nature. Knowledge on the mutation spectra of these genes in
Chinese would be beneficial in understanding the genetic character of this worldwide disease.
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Introduction
Auditoryneuropathy(AN),alsoknownasauditorydys-synchrony
[1], is a special type of sensorineural hearing disorder. This disorder
defined and nominated by Starr in 1996, based on the characters
in auditory tests [2]. The terminology of auditory neuropathy
spectrum disorder (ANSD) was recommend to name the disease in
2008 due to its heterogeneous and multifaceted characteristics [3].
In patients with ANSD, otoacoustic emissions are normal or partly
normal, which reflect the preservation of function in outer hair cells
(OHCs). However, their auditory brainstem responses (ABRs) are
profoundly abnormal or absent, indicating that the disorder lies
either in the inner hair cells (IHCs), in the intervening synapse, or in
the auditory nerve [2,4,5]. The pure-tone audiometric results in
ANSD patients can vary greatly from normal hearing to
severe hearing loss, but the thresholds are elevated higher in the
low-frequency region in most of the patients. The major complaint
of ANSD patients is their difficulty in understanding words,
especially of loud voices or in noisy environments [5].
The prevalence of ANSD in sensorineural hearing loss (SNHL)
can range from 2.4% to 15%, which may be due to the varied
criteria by different researchers [6]. Rance et al. [7] described a
23% prevalence of ANSD within the at-risk neonates. Our former
study showed that 1.37% of patients with SNHL are diagnosed
with ANSD [8]. The etiologies of ANSD can be classified into
three main groups, namely, genetic, infectious, and neonatal/
prenatal risk factors [3,9,10]. Although histories of infections or
risk factors are responsible for some ANSD patients, defined
etiology are rare in majority of these patients, especially those with
hearing loss onset in the second or the third decade [8].
Congenital ANSD, syndromic or non-syndromic, are closely
related with genetic abnormality [3]. Mutations in either the
OTOF (Gene ID: 9381, MIM*603681) or PJVK gene (Gene ID:
494513, MIM*610219) can cause congenital recessive ANSD
[11,12]. Additionally, mutations in GJB2 (Gene ID: 2706,
MIM*121011) and mitochondrial 12S rRNA (Gene ID: 4549,
MIM*561000) have also been detected as the cause of ANSD in
some patients [13,14].
The OTOF gene is responsible for DFNB9 (MIM#601071)
[15] and the non-syndromic recessive ANSD [12]. OTOF gene
mutations have been inferred to be responsible for 2%–3% non-
syndromic hearing losses (NSHL) in some ethnic groups, and most
of these patients meet the diagnostic criteria for ANSD [16,17].
Otoferlin, encoded by OTOF, is critical for exocytosis at the
auditory ribbon synapse in a calcium-dependent manner [18,19].
To date, more than 60 pathogenic variants of the OTOF gene have
been reported in familial or sporadic patients of ANSD and
congenital SNHL [20–22].
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DFNB59 (MIM#610220), and all of them were diagnosed with
ANSD [11]. Homozygous PJVK-mutated knock-in mice showed
mimic phenotype of patients with PJVK mutations, such as
abnormal ABR and preserved function of IHCs and OHCs. The
pejvakin, encoded by PJVK, was detected in the cell bodies of
neurons in the auditory pathway and is believed to be essential in
neural activity [11].
Cochlear implant could be the last resort for patients with
ANSD [23] because hearing aids or medicines are not beneficial to
these patients. Although the outcome in children afflicted with
ANSD is not as good as those with SNHL [24], improvement of
speech perception following cochlear implants has been reported
in some patients [25]. For ANSD patients, the result of cochlear
implant may depend on the location of the lesion. Cochlear
implants provide supraphysiologic electrical stimulation of the
auditory nerve and may improve the synchronicity of the neural
activity. Therefore, cochlear implants may be beneficial for pre-
synaptic ANSD, contrary to post-synaptic ANSD [23]. Otoferlin
and pejvakin work in functionally separate cells. Hence, we infer
that gene screening may be an advantageous method to identify
the subtypes of non-syndromic ANSD and could be a guide for
cochlear implants. Cochlear implantation actually showed good
outcomes in subjects with OTOF mutations [26,27].
Sporadic hearing loss could be the result of non-genetic factors as
well as recessive gene mutations. GJB2 gene mutations can cause
congenital and postlingual hearing loss, with pure-tone threshold
ranging from moderate to profound [28]. Until recently, almost all
mutations responsible for ANSD aredetected incongenitalpatients.
In reality, there is inadequate information regarding the genetic
data in postlingual ANSD patients, especially those whose hearing
disorder is manifested in their second or third decade. The aim of
the presentstudy was to evaluate the variations in OTOF, PJVK,a n d
GJB2 genes, as well as in mitochondrial 12S rRNA, in sporadic
postlingual ANSD patients living in northwest China.
Methods
Patient Recruitment and Clinical Evaluations
We enrolled 76 unrelated patients diagnosed with non-syndromic
ANSD from January 1, 2009 to May 20, 2011. All the patients were
of Chinese Han ethnicity living in northwest China. The case group
comprised 45 females and 31 males, with onset age of hearing loss
varying from 5 to 32 years (X =16.264.6). All the patients denied
any history of ototoxic drug or noise exposure. Syndromic disorders
were previously ruled out in all cases by inquiry and physical
examinations. The control group consisted of 105 matched normal-
hearing subjects.
The diagnostic criteria of ANSD was defined briefly as follows
[4,5]: (1) complaints of hearing loss, with difficulty in word discri-
mination; (2) normal or partially normal distortion product
otoacoustic emissions and tympanometry, but abnormal ABR and
stapedial reflexes; (3) pure-tone audiometries show SNHL; and (4)
negative in computerized tomography scanning of the temporal
bone and/or magnetic resonance hydrography of the inner ear.
The present study was approved by the Institutional Review
Board of the Ethics Committee of China People’s Liberation Army
Xijing Hospital, the Fourth Military Medical University. Informed
consent was signed by the participants and/or their parents prior
to obtaining their blood samples for the genetic study.
Figure 1. Novel pathogenic OTOF mutations in this work and the relation to the functional domains [42]. Blue: 6 C2 domains. Orange:
FerI and FerB domains. Brown: transmembrane domain. Variations of this work are noted under the schematic diagram, and other missense
mutations outside the function domains are shown above it.
doi:10.1371/journal.pone.0024000.g001
Table 1. Probable-pathogenic variants of OTOF identified in 76 patients.
Location Nucleotide change Codon change Occurrence in the present work Occurrence in control References
Exon 12 c.1102G.A p.G368R 1/76 0/105 Present work
Exon 12 c.1194T.A p.D398E 1/76 0/105 [16]
Exon 18 c.2180A.G p.N727S 1/76 0/105 Present work
Intron 28 c.3570+2T.C Splice site 1/76 0/105 Present work
Intron 32 c.4023+1G.A Splice site 1/76 0/105 Present work
Exon 40 C.5026C.T p.R1676C 1/76 0/105 Present work
doi:10.1371/journal.pone.0024000.t001
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PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24000Figure 2. Sequencing chromatograms of novel splice site variants identified in the present work with wild type control. The variants
include c.3570+2T.C and c.4023+1G.A. Corresponding variant locations are arrowed.
doi:10.1371/journal.pone.0024000.g002
Figure 3. Sequencing chromatograms of novel missense mutations identified in the present work with wild type control. The variants
include c.1102G.A, c.2180A.G and c.5026C.T. Corresponding variant locations are arrowed.
doi:10.1371/journal.pone.0024000.g003
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Genomic DNA samples of the participants were extracted from
peripheral venous blood by standard procedures of the Bioteke kit
(DP2102, Bioteke Corp.). We designed 41 pairs and 6 pairs of
primers to amplify DNA fragments containing all exons in the
coding regions of gene OTOF and PJVK, respectively (Table S1
and Table S2 in supplementary document). All the primers were
designed using Primer 3.0 online software and synthesized by
Shenggong DNA Technologies. Polymerase chain reactions (PCR)
were performed in a total volume of 50 mLb y26 Power Taq
PCR MasterMix (PR1700, Bioteke Corp.) with 100 ng of genomic
DNA in MyCycler thermocyclers (Bio-rad Corp.). PCR products
were finally sequenced by ABI 3730Xl DNA Analyzer. The data
were subsequently compared with the wild-type OTOF
(NG_009937.1, NM_194248.2) and PJVK (NG_0012186.1,
NM_001042702.3) sequences, and a panel of 105 controls verified
it. Variations corresponding with the coding region were
numbered as in the otoferlin isoform a (NP_919224.1) and
pejvakin (NP_001036167.1). Meanwhile, the patients were also
subjected to mutation screening for genes commonly associated
with NSHL and some patients of ANSD, namely, the GJB2 and
the mitochondrial 12S rRNA genes.
Results
Identification of OTOF Gene Variants
Among 70 ANSD patients, 7 novel variants were found in
the OTOF gene, including 2 splice site mutations, 3 missense
mutations, and 2 silent variants (Table 1 and Figure 1, and
Table S3 in supplementary document). The splice site mutations
were as follows: (1) c.3570+2T.C, a T to C transition at the
donor site of intron 28; and (2) c.4023+1G.A, a G to A
transition at the donor site of intron 32 (Figure 2). The missense
mutations were as follows: (1) c.1102G.A (p.G368R), a
Figure 4. Evolutionary conservation of the residue altered in novel OTOF mutations. The ClustalW alignment result of the long isoform of
otoferlin among different organisms, including human, dog, cattle, mouse, rat, bird and fish. The locations of mutated amino acids are boxed and
highlight in inversed color.
doi:10.1371/journal.pone.0024000.g004
Figure 5. Sequencing chromatograms of novel pathogenic variant (c.548G.A) in this work with control. Arrow: the variant location.
doi:10.1371/journal.pone.0024000.g005
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nonpolar neutral amino acid glycine to a polar positive amino
acid arginine; (2) c.2180A.G (p.N727S), a transition from A to G
in exon 18 led to a substitution from asparagine to serine; and (3)
c.5026C.T (p.R1676C), a transition from C to T in exon 40
resulted in a substitution from a polar positive amino acid
arginine to a nonpolar neutral amino acid cysteine (Figure 3).
Silent variations include c.3615G.Aa n dc . 3 6 8 4 T .Ai ni s o f o r m
d mRNA (NM_194323.2, Table S3 in supplementary docu-
ment). In addition, we identified a missense mutation c.1194T.A
(p.D398E) in one patient, which had been reported as pathogenic
mutation by other researchers [21]. All these variations were
heterozygously carried by different patients.
We assumed that the splice site mutations and the missense
variants c.1102G . A (p.G368R) were possibly pathogenic because
(1) splice site mutations yielded an incorrect splicing of mRNA and
the missense mutation was located in the functional C2B regions,
which are highly conserved among vertebrate species (Figure 4),
and (2) none of these mutations were observed in 105 unrelated
controls (Table 1). The other novel variations, c.2180A.G
(p.N727S) and c.5026C.T (p.R1676C), were also observed to be
highly conserved from zebrafish to humans, and were absent in the
control (Table 1 and Figure 4). However, whether they are
harmless variants or pathogenic mutations is difficult to elucidate.
Moreover, 15 variants encoding polymorphic changes were
identified, including 4 missense variants, namely, c.157G.A
(p.A53T), c.158C.T (p.A53V), c.244C.T (p.R82C) and
c.4936C.T (p.P1646S); all of which have been reported
previously [21] (Table S3 in supplementary document). We
identified 28 variants in the flanking regions of exons, including 7
novel variants, namely, g.336G.A, g.21153G.C, g.21254T.G,
g.77602G.C, g.81074G.A, g.87599G.A, and g.100441G.A.
Identification of PJVK Gene Variants
We found 3 novel variants in the exons of the PJVK gene,
including 1 missense mutation and 2 silent mutations, which are as
follows: (1) c.548G.A (p.R183Q), a transition from G to A in exon
4 caused a substitution from a basic amino acid arginine to a neutral
aminoacidglutamine(Figure5);and(2)c.921G.Cand c.*2A.C
were silent variants in exon 7 (Table 2). All these variations were
heterozygously carried by different patients. We also identified a
polymorphic variant c.874G.A (p.G292R) in exon 7 [29] and two
variants, g.1611G.A and g.5337C.T, in the introns of PJVK.
We assumed that the missense mutation c.548G.A (p.R183Q) was
possibly pathogenic because: (1) the region is highly conserved among
vertebrate species (Figure 6); (2) the mutation was not observed in 105
unrelated controls (Table 2); and (3) previous study has identified
c.547C.T (p.R183W) as a pathogenic mutation, which emphasized
the importance of the conservation of this region [11].
Identification of GJB2 gene and mitochondrial 12S rRNA
Variants
Wedidnotdetectknownpathogenicvariationsornovelmutation
in the gene GJB2 and mitochondrial 12S rRNA. Some variants
encoding polymorphic changes were detected, including c.79G.A,
c.109G.A and c.341A.G in gene GJB2 and c.663A.G,
c.709G.A, c.750A.G, c.1107T.C and c.1438A.Gi nt h e
mitochondrial 12S rRNA gene.
Discussion
ANSD is closely related to the OTOF gene, which contains 47
coding exons and spans approximately 90 kb, encoding protein
otoferlin [12]. Otoferlin is a fer-1-like protein, containing a
transmembrane domain and 6 C2 domains [30]. In situ
hybridization in neonatal mice cochlea, otoferlin labeling was
dominantly seen in the IHCs, but faintly in the OHCs, spiral
ganglion cells, as well as in the neuroepithelia hair cells of the
utricle, saccule, and semicircular canals [31]. Roux et al. [19]
observed that otoferlin was localized mainly in the ribbon-
associated synaptic vesicles. Data showed that otoferlin is crucial
in IHCs exocytosis and membrane fusion in a Ca
2+-sensitive
Figure 6. Evolutionary conservation of the residue altered in the PJVK gene. The ClustalW of pejvakin are shown among different
organisms, including human, Chimpanzee, dog, cattle, mouse, rat, bird and fish. The locations of mutated amino acids are boxed and highlight in
inversed color.
doi:10.1371/journal.pone.0024000.g006
Table 2. Genetic variants of PJVK identified in 76 patients.
Location Nucleotide change Codon change Occurrence in this work Occurrence in control References
Exon 4 c.548 G.A p.R183Q 1/70 0/105 This work
Exon 7 c.874 G.A p.G292R 19/70 21/105 [41]
Exon 7 c.921G.C p.G307G 1/70 0/105 This work
39 UTR c.*A.C 1/70 1/105 This work
doi:10.1371/journal.pone.0024000.t002
OTOF and PJVK Variants in Chinese ANSD
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synapse [19].
The OTOF gene was first cloned and identified in a Lebanese
family with DFNB9 non-syndromic hearing loss, which was not
originally diagnosed as ANSD [15]. Varga et al. [12] studied four
families with ANSD by linkage and mutation analyses and found that
the OTOF gene is responsible for the hearing loss in three of the
families. Furthermore, Migliosi et al. [32] identified a frequent OTOF
mutant, c.2485C.T (p.Q829X), in Spanishpatients with NSHL. An
international multicenter study confirmed the prevalence and
spectrum of OTOF mutation in Spanish families or subjects of
Spanish ancestry with NSHL [17]. The mutation of p.Q829X in the
OTOF gene is responsible for 2.3%–5.1% NSHL patients [17], most
of who are diagnosed with ANSD. However, the mutation spectrum
of the OTOF gene in the Pakistani and Brazilian populations are
evidently different from those reported in whites[16,33]. Recently, an
OTOF variant study also showed a different mutation spectrum in
ANSD patients in Taiwan and east China [21,22].
In the present study, we identified 2 novel splice site mutations
and 3 novel missense mutations in the OTOF gene within 76
sporadic postlingual ANSD patients. However, we did not detect
other pathologic allelic variants reported previously, not even the
most frequently reported mutations, p.Q829X in Spanish patients
and p.E1700Q in the Taiwanese subjects, who are closer genetically
to our patients [34]. We detected a similar mutation as reported in a
study about ANSD patients east China [21]. We assumed that the
novel splice site mutations and the missense variant c.1102G.A
(p.G368R) are possibly pathogenic because they are functionally
important and highly conserved among species. The other 2 novel
variations were located outside the functional domains. Although
the amino acids are also demonstrated to be highly conserved from
the zebrafish to humans, and absent in the control, and a batch of
pathogenic missense mutations were located outside the functional
domains, whether these variations are harmless variants or
pathogenic mutations are difficult to establish because we were
unable to find other pathogenic mutations.
PJVK gene, encoding protein pejvakin, consists of 7 exons
spanning 9.8 kb of genomic sequence. Homozygous PJVK-
mutated knock-in mice, qualified with ANSD, exhibited abnormal
ABR indicative of neuronal dysfunction along the auditory
pathway and normal otoacoustic emissions that indicated well
preserved hair cells [11]. Pejvakin was detected in the cell bodies of
neurons of the afferent auditory pathway. Delmaghani et al. [11]
concluded that pejvakin is essential in the auditory pathway
neuronal activity. Apparently, the PJVK gene is important in
ANSD patients, although its mutations are also related to SNHL
[29,35]. Furthermore, pejvakin- mutated mice showed SNHL with
preserved IHCs and OHCs [11,36].
Delmaghani et al. [11] detected the R183W mutation in a recessive
ANSD family and proved that R183W mutation is pathogenic in the
knock-in mouse model. At the same position, we detected a missense
mutation c.548G.A (p.R183Q), which altered arginine to glutamine.
We believed that the R183Q variation is another pathogenic mutation
in the PJVK gene. We did not detect other pathogenic mutations in our
patients. Collin et al. [29] analyzed the carrying rate of PJVK mutations
in 151 patients, and concluded that the PJVK gene mutations do not
primarily cause NSHL. Nevertheless, considering the specificity of cells
where the PJVK gene functioned [11], the mutation spectra in ANSD
patients should be monitored continuously.
GJB2 gene and mitochondrial12S rRNA gene are two of the
most prevalent pathogenic genes responsible for NSHL [37], and
mutations in both genes had been identified in sporadic AN
patients [13,14]. However, we did not detect pathogenic mutations
in the GJB2 gene or the 12S rRNA gene in our patients. Additional
ANSD patients should be enrolled to study the relationship
between these two genes and ANSD.
Clinically, two single heterozygous genes, GJB2 and GJB6,h a v e
been found responsible for NSHL patients [38]. In patients with
enlarged vestibular aqueduct syndrome, both single heterozygous
genes SLC26A4 (MIM*605646) and KCNJ10 (MIM*602208) induced
the hearing loss in these patients [39]. In a previous study, a single
heterozygous variant in OTOF gene is linked as pathogenic [12]. In
the present study, all patients carried single heterozygous pathogenic
variants of gene OTOF or PJVK. We supposed the possibility of other
genes participating in the ANSD pathogenesis cooperation with
OTOF and PJVK or that the disorder resulted from a combination of
genetic and environmental conditions. Candidate genes for explora-
tion could be the genes encoding ion channel proteins or genes
participating in the mitochondria [40]. On the other hand, copy
number variations could be another possibility in patients with or
without heterozygous variants because the deletion of exons or the
entire gene in one or both allele may be missed by amplification and
direct sequencing. Our future work would focus on the detection of
copy number variations in patients with single heterozygous variants.
Furthermore, most of our patients live in the mountain and rural
areas; thus, environmental etiology should also be considered.
Santarelli et al. [33] noted that ANSD patients with OTOF gene
mutations exhibit some variations from other ANSD patients,
which could predict the results of cochlear implantation [26,27].
However, none of our patients with OTOF mutations underwent
operation for cochlear implantation, considering the pressure of
economy and the risk of inefficiency. Two ANSD patients without
variants in either of the genes had cochlear implant. A 5-year-old
girl with profound hearing loss significantly improved, in contrast
to a 15-year old boy with moderate hearing who showed no
improvement in words understanding. The difference in their
results still needs to be explored in further studies.
In conclusion, we identified 3 novel possible pathogenic variants
and 1 known probable pathogenic mutation of the OTOF gene in
76 Chinese ANSD patients. We identified 1 novel possible
pathogenic variant of the PJVK gene in the same group. The
special mutation spectra of these 2 genes in Chinese subjects could
be the result of across-race diversity and could be beneficial in
understanding the worldwide occurrence of ANSD.
Supporting Information
Table S1 PCR primers for OTOF gene screening.
(DOC)
Table S2 PCR primers for PJVK gene screening.
(DOC)
Table S3 Non-pathogenic variants of OTOF gene iden-
tified in this study.
(DOC)
Acknowledgments
We thank the patients and their families for their kind cooperation in the
present work. We are also grateful to the audiologists Gao Lei, Xie Juan
and Han Li-ping for their diagnostic work.
Author Contributions
Conceived and designed the experiments: Q-Jh. Performed the experi-
ments: WJ. Analyzed the data: WJ F-Yy. Contributed reagents/materials/
analysis tools: WS-j LP-F WJ-l. Wrote the paper: WJ F-Yy.
OTOF and PJVK Variants in Chinese ANSD
PLoS ONE | www.plosone.org 6 September 2011 | Volume 6 | Issue 9 | e24000References
1. Berlin CI, Hood L, Morlet T, Rose K, Brashears S (2003) Auditory neuropathy/
dys-synchrony: diagnosis and management. Ment Retard Dev Disabil Res Rev
9: 225–231.
2. Starr A, Picton TW, Sininger Y, Hood LJ, Berlin CI (1996) Auditory
neuropathy. Brain 119(Pt 3): 741–753.
3. Manchaiah VK, Zhao F, Danesh AA, Duprey R (2010) The genetic basis of
auditory neuropathy spectrum disorder (ANSD). Int J Pediatr Otorhinolaryngol.
4. Starr A, Sininger YS, Pratt H (2000) The varieties of auditory neuropathy.
J Basic Clin Physiol Pharmacol 11: 215–230.
5. Wang J, Gao L, Xue F, Meng M, Zha D, et al. (2002) [Auditory neuropathy].
Lin Chuang Er Bi Yan Hou Ke Za Zhi 16: 518–520.
6. Tang TP, McPherson B, Yuen KC, Wong LL, Lee JS (2004) Auditory
neuropathy/auditory dys-synchrony in school children with hearing loss:
frequency of occurrence. Int J Pediatr Otorhinolaryngol 68: 175–183.
7. Rance G, Beer DE, Cone–Wesson B, Shepherd RK, Dowell RC, et al. (1999)
Clinical findings for a group of infants and young children with auditory
neuropathy. Ear Hear 20: 238–252.
8. Wang J, Shi L, Xue F, Sun W, Gao L, et al. (2007) Differential Audiological
Assessment of Patients with Auditory Neuropathy. Journal of Audiology and
Speech Pathology 15: 89–97.
9. Kirkim G, Serbetcioglu B, Erdag TK, Ceryan K (2008) The frequency of
auditory neuropathy detected by universal newborn hearing screening program.
Int J Pediatr Otorhinolaryngol 72: 1461–1469.
10. Robertson CM, Howarth TM, Bork DL, Dinu IA (2009) Permanent bilateral
sensory and neural hearing loss of children after neonatal intensive care because
of extreme prematurity: a thirty-year study. Pediatrics 123: e797–e807.
11. Delmaghani S, del CF, Michel V, Leibovici M, Aghaie A, et al. (2006) Mutations
in the gene encoding pejvakin, a newly identified protein of the afferent auditory
pathway, cause DFNB59 auditory neuropathy. Nat Genet 38: 770–778.
12. Varga R, Kelley PM, Keats BJ, Starr A, Leal SM, et al. (2003) Non-syndromic
recessive auditory neuropathy is the result of mutations in the otoferlin (OTOF)
gene. J Med Genet 40: 45–50.
13. Cheng X, Li L, Brashears S, Morlet T, Ng SS, et al. (2005) Connexin 26 variants
and auditory neuropathy/dys-synchrony among children in schools for the deaf.
Am J Med Genet A 139: 13–18.
14. Wang Q, Li R, Zhao H, Peters JL, Liu Q, et al. (2005) Clinical and molecular
characterization of a Chinese patient with auditory neuropathy associated with
mitochondrial 12S rRNA T1095C mutation. Am J Med Genet A 133A: 27–30.
15. Yasunaga S, Grati M, Cohen–Salmon M, El–Amraoui A, Mustapha M, et al.
(1999) A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes
DFNB9, a nonsyndromic form of deafness. Nat Genet 21: 363–369.
16. Romanos J, Kimura L, Favero ML, Izarra FA, de Mello AM, et al. (2009) Novel
OTOF mutations in Brazilian patients with auditory neuropathy. J Hum Genet
54: 382–385.
17. Rodriguez–Ballesteros M, Reynoso R, Olarte M, Villamar M, Morera C, et al.
(2008) A multicenter study on the prevalence and spectrum of mutations in the
otoferlin gene (OTOF) in subjects with nonsyndromic hearing impairment and
auditory neuropathy. Hum Mutat 29: 823–831.
18. Zanazzi G, Matthews G (2009) The molecular architecture of ribbon
presynaptic terminals. Mol Neurobiol 39: 130–148.
19. Roux I, Safieddine S, Nouvian R, Grati M, Simmler MC, et al. (2006) Otoferlin,
defective in a human deafness form, is essential for exocytosis at the auditory
ribbon synapse. Cell 127: 277–289.
20. Zadro C, Ciorba A, Fabris A, Morgutti M, Trevisi P, et al. (2010) Five new
OTOF gene mutations and auditory neuropathy. Int J Pediatr Otorhinolaryngol
74: 494–498.
21. Wang DY, Wang YC, Weil D, Zhao YL, Rao SQ, et al. (2010) Screening
mutations of OTOF gene in Chinese patients with auditory neuropathy,
including a familial case of temperature-sensitive auditory neuropathy. BMC
Med Genet 11: 79.
22. Chiu YH, Wu CC, Lu YC, Chen PJ, Lee WY, et al. (2010) Mutations in the
OTOF gene in Taiwanese patients with auditory neuropathy. Audiol Neurootol
15: 364–374.
23. Gibson WP, Graham JM (2008) Editorial: ‘auditory neuropathy’ and cochlear
implantation - myths and facts. Cochlear Implants Int 9: 1–7.
24. Miyamoto RT, Kirk KI, Renshaw J, Hussain D (1999) Cochlear implantation in
auditory neuropathy. Laryngoscope 109: 181–185.
25. Rance G, Barker EJ (2008) Speech perception in children with auditory
neuropathy/dyssynchrony managed with either hearing AIDS or cochlear
implants. Otol Neurotol 29: 179–182.
26. Rodriguez–Ballesteros M, del CF, Martin Y, Moreno–Pelayo MA, Morera C,
et al. (2003) Auditory neuropathy in patients carrying mutations in the otoferlin
gene (OTOF). Hum Mutat 22: 451–456.
27. Rouillon I, Marcolla A, Roux I, Marlin S, Feldmann D, et al. (2006) Results of
cochlear implantation in two children with mutations in the OTOF gene.
Int J Pediatr Otorhinolaryngol 70: 689–696.
28. Pollak A, Sko ´rka A, Mueller–Malesin ´ska M, Kostrzewa G, Kisiel B, et al. (2007)
M34T and V37I mutations in GJB2 associated hearing impairment: evidence for
pathogenicity and reduced penetrance. Am J Med Genet A 21: 2534–2543.
29. Collin RW, Kalay E, Oostrik J, Caylan R, Wollnik B, et al. (2007) Involvement
of DFNB59 mutations in autosomal recessive nonsyndromic hearing impair-
ment. Hum Mutat 28: 718–723.
30. Yasunaga S, Grati M, Chardenoux S, Smith TN, Friedman TB, et al. (2000)
OTOF encodes multiple long and short isoforms: genetic evidence that the long
ones underlie recessive deafness DFNB9. Am J Hum Genet 67: 591–600.
31. Beurg M, Safieddine S, Roux I, Bouleau Y, Petit C, et al. (2008) Calcium- and
otoferlin-dependent exocytosis by immature outer hair cells. J Neurosci 28:
1798–1803.
32. Migliosi V, Modamio–Høybjør S, Moreno–Pelayo MA, Rodrı ´guez–
Ballesteros M, Villamar M, et al. (2002) Q829X, a novel mutation in the gene
encoding otoferlin (OTOF), is frequently found in Spanish patients with
prelingual non-syndromic hearing loss. J Med Genet 39: 502–506.
33. Choi BY, Ahmed ZM, Riazuddin S, Bhinder MA, Shahzad M, et al. (2009)
Identities and frequencies of mutations of the otoferlin gene (OTOF) causing
DFNB9 deafness in Pakistan. Clin Genet 75: 237–243.
34. McClellan J, King MC (2010) Genetic heterogeneity in human disease. Cell 141:
210–217.
35. Ebermann I, Walger M, Scholl HP, Charbel IP, Luke C, et al. (2007) Truncating
mutation of the DFNB59 gene causes cochlear hearing impairment and central
vestibular dysfunction. Hum Mutat 28: 571–577.
36. Schwander M, Sczaniecka A, Grillet N, Bailey JS, Avenarius M, et al. (2007) A
forward genetics screen in mice identifies recessive deafness traits and reveals
that pejvakin is essential for outer hair cell function. J Neurosci 27: 2163–2175.
37. Hilgert N, Smith RJ, Van Camp G (2009) Forty-six genes causing nonsyndromic
hearing impairment: which ones should be analyzed in DNA diagnostics? Mutat
Res 681: 189–196.
38. Belintani PV, Maria GBE, Lucia SE, Victor MJ (2004) Prevalence of the GJB2
mutations and the del(GJB6-D13S1830) mutation in Brazilian patients with
deafness. Hear Res 196: 87–93.
39. Yang T, Gurrola JN, Wu H, Chiu SM, Wangemann P, et al. (2009) Mutations of
KCNJ10 together with mutations of SLC26A4 cause digenic nonsyndromic
hearing loss associated with enlarged vestibular aqueduct syndrome. Am J Hum
Genet 84: 651–657.
40. Cacace AT, Pinheiro JM (2011) The Mitochondrial Connection in Auditory
Neuropathy. Audiol Neurootol 16: 398–413.
41. Hashemzadeh, C. M, et al. (2007) Novel mutations in the pejvakin gene are
associated with autosomal recessive non-syndromic hearing loss in Iranian
families. Clin Genet 72: 261–263.
42. Jime ´nez JL, Bashir R (2007) In silico functional and structural characterisation of
ferlin proteins by mapping disease-causing mutations and evolutionary
information onto three-dimensional models of their C2 domains. J Neurol Sci
260: 114–123.
OTOF and PJVK Variants in Chinese ANSD
PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e24000